|
home
|
corporate
|
investors
|
products
|
clinical trials
|
partnering
|
contact
TSX: HBP
-
NYSE Amex: HBP
-
Frankfurt: HBP
|
Topical Interferon Alpha-2b
|
L-DOS47
L-DOS47
No clinical trial are currently underway
